SpringWorks Therapeutics, Inc. - common stock (SWTX) earnings
SWTX earnings moved a median of -0.64% by the close. Quarterly and annual SWTX reports and results, each read against the price at its own news timestamp. Back to the SWTX overview →
14 measured SWTX earnings events.
Where these SWTX earnings landedvs 14 measured SWTX earnings reactions
| Middle 50% of SWTX earnings reactions | -7.38% to +3.24% |
|---|---|
| Median reaction (to close) | -0.64% |
| Measured reactions | 14 |
Point-in-time · zero look-ahead
Half of the 14 SWTX earnings events with a measured close landed between -7.38% and +3.24%; 43% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q SpringWorks Therapeutics For: Mar 31 | SEC filing · Form 10-Q | -0.07% | -0.13% | |
| Form 10-K SpringWorks Therapeutics For: Dec 31 | SEC filing · Form 10-K | -2.85% | -2.81% | |
| Form 10-Q SpringWorks Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +7.15% | +10.37% | |
| SpringWorks Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights | Press release | +7.15% | +10.37% | |
| SpringWorks Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 | Press release | +0.90% | -1.15% | |
| Form 10-Q SpringWorks Therapeutics For: Jun 30 | SEC filing · Form 10-Q | -3.46% | -15.18% | |
| SpringWorks Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights | Press release | -3.46% | -15.18% | |
| SpringWorks Therapeutics to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024 | Press release | -0.96% | +3.85% | |
| Form 10-Q SpringWorks Therapeutics For: Mar 31 | SEC filing · Form 10-Q | -8.63% | -8.74% | |
| SpringWorks Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Business Updates | Press release | -8.63% | -8.74% | |
| SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024 | Press release | -1.46% | -3.32% | |
| Form 10-K SpringWorks Therapeutics For: Dec 31 | SEC filing · Form 10-K | +3.85% | +8.16% | |
| Form 10-Q SpringWorks Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +0.88% | +1.41% | |
| SpringWorks Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights | Press release | +0.88% | +1.41% |
Keep exploring
More SWTX: analyst actions → · SEC filings → · SWTX overview →